These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1112 related articles for article (PubMed ID: 3584988)

  • 1. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B; Katz J; Gottlieb M
    J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
    Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
    Santoni A; Herberman RB; Holden HT
    J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME; Kim YB
    J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations.
    de Landazuri MO; Silva A; Alvarez J; Herberman RB
    J Immunol; 1979 Jul; 123(1):252-8. PubMed ID: 376742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
    Graves SS; Bramhall J; Bonavida B
    J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.
    Ljunggren K; Karlson A; Fenyö EM; Jondal M
    Clin Exp Immunol; 1989 Feb; 75(2):184-9. PubMed ID: 2649286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity within the population of NK and K cells.
    Jensen PJ; Koren HS
    J Immunol; 1980 Jan; 124(1):395-8. PubMed ID: 6985645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the cytotoxic activities of different human lymphoid tissues.
    Durántez A; de Landazuri MO; Silva A; Alvarez J; Kreisler M
    J Clin Lab Immunol; 1979 Apr; 2(1):59-65. PubMed ID: 95808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with non-Hodgkin's lymphoma.
    Metha BA; Advani SH; Nadkarni SJ
    Neoplasma; 1988; 35(1):61-8. PubMed ID: 3352838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
    Roozemond RC; Bonavida B
    J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.